1. Home
  2. ADMA vs TMHC Comparison

ADMA vs TMHC Comparison

Compare ADMA & TMHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • TMHC
  • Stock Information
  • Founded
  • ADMA 2004
  • TMHC 1936
  • Country
  • ADMA United States
  • TMHC United States
  • Employees
  • ADMA N/A
  • TMHC N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • TMHC Homebuilding
  • Sector
  • ADMA Health Care
  • TMHC Consumer Discretionary
  • Exchange
  • ADMA Nasdaq
  • TMHC Nasdaq
  • Market Cap
  • ADMA 5.1B
  • TMHC 5.9B
  • IPO Year
  • ADMA N/A
  • TMHC 2013
  • Fundamental
  • Price
  • ADMA $16.21
  • TMHC $69.69
  • Analyst Decision
  • ADMA Strong Buy
  • TMHC Strong Buy
  • Analyst Count
  • ADMA 3
  • TMHC 8
  • Target Price
  • ADMA $27.67
  • TMHC $79.38
  • AVG Volume (30 Days)
  • ADMA 2.9M
  • TMHC 1.1M
  • Earning Date
  • ADMA 11-06-2025
  • TMHC 10-22-2025
  • Dividend Yield
  • ADMA N/A
  • TMHC N/A
  • EPS Growth
  • ADMA 469.09
  • TMHC 28.80
  • EPS
  • ADMA 0.85
  • TMHC 8.67
  • Revenue
  • ADMA $474,174,000.00
  • TMHC $8,403,420,000.00
  • Revenue This Year
  • ADMA $21.08
  • TMHC N/A
  • Revenue Next Year
  • ADMA $25.98
  • TMHC N/A
  • P/E Ratio
  • ADMA $19.06
  • TMHC $8.20
  • Revenue Growth
  • ADMA 43.58
  • TMHC 13.77
  • 52 Week Low
  • ADMA $13.50
  • TMHC $51.90
  • 52 Week High
  • ADMA $25.67
  • TMHC $75.49
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 39.23
  • TMHC 57.63
  • Support Level
  • ADMA $15.74
  • TMHC $68.98
  • Resistance Level
  • ADMA $17.17
  • TMHC $71.27
  • Average True Range (ATR)
  • ADMA 0.51
  • TMHC 1.39
  • MACD
  • ADMA -0.08
  • TMHC 0.05
  • Stochastic Oscillator
  • ADMA 23.51
  • TMHC 61.79

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About TMHC Taylor Morrison Home Corporation

Taylor Morrison Home Corp is an American residential construction company engaged in residential homebuilding and the development of lifestyle communities. It designs, builds, and sells single and multi-family detached and attached homes in traditionally high growth markets for entry level, move-up, and resort lifestyle buyers. The company has four reportable segments: East, Central, West, and Financial Services. The majority of the company's revenue is derived from its West Segment.

Share on Social Networks: